ERM-001

N/A

Report date: 2024/06/11 09:30:36
NME

Base Information

Drug NameERM-001
Drug Alias NameERM-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRetinol-binding protein 4 inhibitorsTransthyretin inhibitors
TargetsRetinol-binding protein 4Transthyretin
Therapy Area/IndicationsGeographic AtrophyStargardt Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesErmaris Bio
China Registration ClassN/A

Develop Information

Active CompaniesErmaris Bio
Inactive CompaniesN/A
Active IndicationsGeographic AtrophyStargardt Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A